Urologic Oncology: Seminars and Original Investigations

Title Publication Date Language Citations
Molecular markers of prostate cancer2006/11/01English52
The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes2014/01/01English52
Expression of potential molecular markers in prostate cancer: Correlation with clinicopathological outcomes in patients undergoing radical prostatectomy2010/03/01English51
Identification of cell-free microRNAs in the urine of patients with prostate cancer2015/01/01English51
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data2013/11/01English51
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model1Contributed equally and share first authorship.2014/11/01English51
Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy2017/06/01English51
A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment 1 1MPS is an investor in and consultant for Urogen. SAP is consultant and advisor for Vaccinex. The remaining authors have nothing to disclose.2017/01/01English51
Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: Feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up2013/01/01English50
Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists2013/10/01English50
Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement2015/03/01English50
Disparities in bladder cancer2012/01/01English50
The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure11The first author has a PhD Grant (SFRH/BD/43399/2008) and J.A.F. has a Postdoctoral Grant (SFRH/BPD/66288/2009) from FCT—Fundação para a Ciência e Tecnologia, co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF). We thank to LPCC, Portuguese League Against Cancer (NRNorte) for their support. This work was also supported by Fundação para a Ciência e a Tecnologia (FCT, Portugal), European Union, QREN, FEDER and COMPETE for funding the QOPNA research unit (project PEst-C/QUI/UI0062/2013).2Both authors have equally contributed to the work.2014/05/01English50
PD-1 checkpoint inhibition: Toxicities and management2017/12/01English50
Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma2010/07/01English50
The effect of minimally invasive prostatectomy on practice patterns of American urologists2016/06/01English49
The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status2009/05/01English49
Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis2017/08/01English49
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates2013/05/01English49
Surgical margin length and location affect recurrence rates after robotic prostatectomy2015/03/01English49
Cav1.3 channel α1D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers11This work was partially supported by grants from DoD PCRP program (W81XWH-09-1-0455) and KUMC Valk Foundation to Dr Benyi Li, and grants from China Natural Science Foundation to Dr Benyi Li (NSFC #81172427) and Dr Jun Yang (NSFC #81101927). This project was also supported by the “Chutian Scholar” program funded by Hubei Province of China dedicated to China Three Gorges University.2014/07/01English49
Surveillance for renal cell carcinoma: Why and how? When and how often?2008/09/01English49
MicroRNAs and their potential for translation in prostate cancer2009/05/01English49
Sexual intimacy in heterosexual couples after prostate cancer treatment: What we know and what we still need to learn2009/03/01English48
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer2004/09/01English48
Meta-analysis in medical research: Potentials and limitations2008/05/01English48
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma2008/09/01English48
Impact of hospital case volume on testicular cancer outcomes and practice patterns2018/01/01English48
Prognostic significance of markers of systemic inflammatory response in patients with non–muscle-invasive bladder cancer2016/11/01English48
Pathobiology and prognosis of chromophobe renal cell carcinoma2008/11/01English48